Carthera announced today that it received FDA and European orphan drug designation (ODD) for the use of carboplatin with its SonoCloud. The designation allows Paris, France-based Carthera to use carboplatin chemotherapy in the treatment of malignant glioma. Carthera conducts this treatment through the use of SonoCloud, a device that emits ultrasound to temporarily increase the […]
CarThera
Carthera enrolls first patient in ultrasound drug delivery trial
Carthera announced today that it enrolled the first patient in the SONOBIRD pivotal trial for its SonoCloud device. Paris, France-based Carthera designed SonoCloud to treat a wide range of brain disorders. The device emits ultrasound to temporarily increase the permeability of blood vessels in the brain, improving therapeutic molecule delivery. After implantation in the skull, […]
Carthera closes $40M Series B to support SonoCloud
Carthera announced today that it closed a $40 million Series B financing round to support its ultrasound-based SonoCloud device. Paris-based Carthera, a spinoff from Sorbonne University, develops SonoCloud to treat a wide range of brain disorders. SonoCloud emits ultrasound to temporarily increase the permeability of blood vessels in the brain, improving therapeutic molecule delivery. After […]
FDA grants breakthrough nod for Carthera’s SonoCloud-9
Carthera announced today that it received FDA breakthrough device designation for its SonoCloud-9 system. Paris-based Carthera designed SonoCloud-9 for implantation in a skull window below the skin. Once in place, the device becomes invisible. When activated for a few minutes using a transdermal needle connected to an external control unit, it uses low-intensity pulsed ultrasound […]
Study produces ‘promising results’ for Carthera’s SonoCloud tech for mild Alzheimer’s symptoms
Carthera announced positive results from a trial evaluating the safety and efficacy of the use of its SonoCloud technology. Results from the investigator-sponsored trial of SonoCloud in patients with mild Alzheimer’s Disease (AD) were published this week in the Alzheimer’s Research & Therapy Journal. Paris-based Carthera designed SonoCloud, an implantable 1 MHz ultrasound device, to be […]
CarThera collects $14.3M
CarThera announced today that it received a $2.3 million (€2 million) grant and $12 million (€10.5 million) in equity, totaling $14.3 million. Paris-based CarThera was selected by the EIC Accelerator Pilot to receive the funds as it develops its Domeus project for treating glioblastoma patients. In addition to the money, CarThera is also slated to […]
